Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny

Jun 28 2018

• By Eileen Francis

Related Content

Industry News Roundup

Sep 09 2014

US FDA Moves Homeopathic Drug Enforcement To Risk-Based Approach

Dec 19 2017

OTC Homeopathic Market Could Shrink Under US FDA Risk-Based Oversight, Trade Groups Say

Jun 28 2018

FTC Homeopathic Advertising Review Spurs Broader Disclaimer Suggestion, Opens New Stage For RCT Debate

Sep 22 2015

OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC

Nov 16 2016

Additional Topics

United States Advertising, Marketing & Sales Drug Approval Standards FDA Regulation OTC Drugs Consumer

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window